Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin

PURPOSE: Efavirenz-based combination antiretroviral therapy (cART) is associated with neuropsychiatric adverse events. We investigated the time to onset, duration, clinical implications, impact of pharmacogenetic variations, and anti-tuberculosis co-treatment on efavirenz-associated neuropsychiatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Mugusi, Sabina, Ngaimisi, Eliford, Janabi, Mohammed, Mugusi, Ferdinand, Minzi, Omary, Aris, Eric, Bakari, Muhammad, Bertilsson, Leif, Burhenne, Juergen, Sandstrom, Eric, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Pharmacogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182598/
https://www.ncbi.nlm.nih.gov/pubmed/30003275
http://dx.doi.org/10.1007/s00228-018-2499-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182598/
https://www.ncbi.nlm.nih.gov/pubmed/30003275
http://dx.doi.org/10.1007/s00228-018-2499-0

Ejemplares similares